SCHEMBL358919

SCHEMBL358919

CC(N)CN1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
ANPEP P15144 1/20 0.48
ERAP2 Q6P179 1/20 0.48
MAPT P10636 2/20 0.41
ATM Q13315 2/20 0.41
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
HRH3 Q9Y5N1 3/20 0.38
CHRM2 P08172 2/20 0.38
ADRA2B P18089 2/20 0.38
DRD3 P35462 2/20 0.38
SIGMAR1 Q99720 2/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 1/20 0.37
CYP2D6 P10635 1/20 0.36
ADRA2C P18825 1/20 0.36
CHRM3 P20309 1/20 0.36
OPRD1 P41143 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18205131 1.00 MEN1 (0.50) MEN1KMT2AANPEPERAP2MAPT
SCHEMBL15768017 1.00 MEN1 (0.50) MEN1KMT2AANPEPERAP2MAPT
SCHEMBL20357058 1.00 MEN1 (0.50) MEN1KMT2AANPEPERAP2MAPT
SCHEMBL6783279 1.00 MEN1 (0.50) MEN1KMT2AANPEPERAP2MAPT
SCHEMBL996901 0.97
SCHEMBL12381528 0.97
SCHEMBL12714698 0.97
SCHEMBL23885878 0.92
SCHEMBL6680924 0.86
SCHEMBL1043849 0.86 PIK3CD (0.39) MEN1KMT2AANPEPERAP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 290 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151136-A1 CATALYST COMPOSITION FOR POLYURETHANES MOMENTIVE PERFORMANCE MATERIALS INC. 2023-05-18 US claimed
EP-4114566-A1 CATALYST COMPOSITION FOR POLYURETHANES Momentive Performance Materials Inc. (US) 2023-01-11 EP claimed
CN-115243789-A Catalyst composition for polyurethane 迈图高新材料公司 2022-10-25 CN claimed
EP-2448667-B1 ACID GAS SCRUBBING COMPOSITION AND PROCESS NALCO CO (US) 2019-06-26 EP claimed
EP-2640507-B1 ACID GAS ABSORBENT COMPOSITION NALCO CO (US) 2019-05-08 EP claimed
EP-2448654-B1 ACID GAS SCRUBBING COMPOSITION NALCO CO (US) 2019-05-01 EP claimed
US-9233338-B2 Composition for treating acid gas NALCO COMPANY (US) 2016-01-12 US claimed
US-8765951-B2 Acid gas absorbent composition NALCO COMPANY (US) 2014-07-01 US claimed
US-8765083-B2 Acid gas absorbent composition NALCO COMPANY (US) 2014-07-01 US claimed
US-20140138578-A1 COMPOSITION FOR TREATING ACID GAS APERGY ESP SYSTEMS, LLC 2014-05-22 US claimed
US-20080247976-A1 water-resistant cosmetic or dermatological compositions for the UV-photoprotection of human skin and/or hair with enhanced stability to water DUEVA-KOGANOV OLGA V 2008-10-09 US claimed
EP-1633348-B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ELAN PHARM INC (US) 2008-10-08 EP claimed
US-7432379-B2 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists ELAN PHARMACEUTICALS, INC. (US) 2008-10-07 US claimed
US-20070032475-A1 Novel compounds useful for bradykinin B1 receptor antagonism ELAN PHARMACEUTICALS, INC. 2007-02-08 US claimed
US-20060281733-A1 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carvoxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases ELAN PHARMACEUTICALS, INC. 2006-12-14 US claimed
EP-1633348-A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES Elan Pharmaceuticals, Inc. (US) 2006-03-15 EP claimed
US-20050020659-A1 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists ELAN PHARMACEUTICALS, INC. 2005-01-27 US claimed
WO-2004098589-A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ELAN PHARMACEUTICALS, INC. (US) 2004-11-18 WO claimed
EP-0311157-B1 Dispersant EFKA CHEMICALS BV (NL) 1993-11-10 EP claimed
EP-0311157-A1 Dispersant EFKA-CHEMICALS B.V. (NL) 1989-04-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080247976-A1 water-resistant cosmetic or dermatological compositions for the UV-photoprotection of human skin and/or hair with enhanced stability to water CUTA, POLR1C, MSH6 MEN1 1461/4885KMT2A 3806/4885ANPEP 3230/4885
US-20050020659-A1 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists BDKRB1, BDKRB2, BRS3 MEN1 1010/4885KMT2A 3940/4885ANPEP 1371/4885
US-20070032475-A1 Novel compounds useful for bradykinin B1 receptor antagonism BDKRB1, BDKRB2, NPBWR1 MEN1 997/4885KMT2A 4091/4885ANPEP 928/4885
US-20060281733-A1 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carvoxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases BDKRB1, BDKRB2, CNR1 MEN1 3044/4885KMT2A 2589/4885ANPEP 3064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.